Docetaxel 80mg/4ml Inj, 4ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication safely and effectively, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the instructions closely. This medication is administered as an intravenous infusion over a specified period.
To minimize the risk of severe side effects, a steroid medication like dexamethasone will be given before administering this drug. However, it's essential to note that this precaution may not completely eliminate the risk of these side effects in all individuals. Discuss any concerns with your doctor. If the steroid medication is not taken as directed, inform your doctor promptly.
Before receiving this medication, ensure you are not dehydrated. Consult your doctor to determine if you need to drink additional fluids before the infusion.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult your doctor, nurse, or pharmacist for guidance on proper storage procedures.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Maintain good hygiene to prevent infections, especially hand washing.
- Avoid contact with people who are sick or have infections.
- Report any signs of infection (fever, chills, sore throat) immediately.
- Stay well-hydrated unless advised otherwise by your doctor.
- Manage fatigue by balancing rest and light activity.
- Use a soft toothbrush and rinse mouth frequently to prevent mouth sores.
- Avoid alcohol and tobacco.
- Discuss any over-the-counter medications, supplements, or herbal products with your doctor before taking them, especially grapefruit products.
- Use effective contraception during treatment and for a period after, as advised by your doctor.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
* **Neutropenia:** The most frequent and severe adverse reaction is neutropenia, which may result in infections, including sepsis and septic shock, which can be fatal. Frequent monitoring of complete blood counts is necessary.
* **Hypersensitivity Reactions:** Severe hypersensitivity reactions characterized by hypotension, bronchospasm, or generalized rash/erythema have occurred. Premedication with corticosteroids is required.
* **Fluid Retention:** Severe fluid retention has occurred. Premedication with corticosteroids is required.
* **Liver Impairment:** Patients with impaired hepatic function are at increased risk for severe adverse reactions, including fatal outcomes, due to increased docetaxel plasma concentrations. Docetaxel should not be given to patients with severe hepatic impairment.
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum, painful urination, mouth sores, or a wound that won't heal.
Signs of bleeding: vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, bleeding gums, abnormal vaginal bleeding, unexplained bruises or bruising that worsens, or uncontrollable bleeding.
Signs of lung or breathing problems: shortness of breath, breathing difficulties, cough, or fever.
Dizziness or fainting.
Abnormal or rapid heartbeat.
Unusual burning, numbness, or tingling sensations.
Muscle weakness.
Additional Important Warnings
If the medication leaks from the vein during administration, it can cause tissue damage. Inform your nurse immediately if you experience redness, burning, pain, swelling, blisters, skin sores, or fluid leakage at the injection site.
This medication may cause a condition called cystoid macular edema (CME), which can affect your vision. You may need regular eye exams while taking this medication. If you notice any changes in your vision, such as blurred vision or loss of vision, contact your doctor right away.
Severe bowel problems can occur, sometimes as early as the first day of symptoms, and can be life-threatening. Seek medical help immediately if you experience stomach pain (with or without fever), tender stomach, or diarrhea.
Liver problems, although rare, can occur and may be fatal. Contact your doctor immediately if you experience dark urine, fatigue, decreased appetite, nausea, stomach pain, light-colored stools, vomiting, or yellowing of the skin or eyes.
Tumor lysis syndrome (TLS) is a potentially life-threatening condition that can occur with this medication. Seek medical help immediately if you experience rapid or abnormal heartbeat, fainting, difficulty urinating, muscle weakness or cramps, nausea, vomiting, diarrhea, or loss of appetite. Discuss ways to prevent TLS with your doctor.
Severe skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), can occur. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin, skin irritation (with or without fever), red or irritated eyes, or sores in your mouth, throat, nose, or eyes.
Other Possible Side Effects
Not everyone will experience side effects, and many people may only have mild or minor side effects. However, if you experience any of the following, contact your doctor or seek medical help:
Mouth irritation or mouth sores.
Changes in nail appearance.
Changes in taste.
Muscle or joint pain.
Flushing.
Eye redness.
Excessive tearing.
Weight loss.
Changes in menstrual periods.
Constipation, diarrhea, nausea, vomiting, or decreased appetite (common side effects; discuss ways to manage them with your doctor).
Hair loss (usually temporary, but in some cases, hair growth may not return to normal).
Fatigue or weakness (may last from a few days to several weeks; contact your doctor if severe or persistent).
Reporting Side Effects
If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever (temperature 100.4°F or higher) or chills
- Unusual bleeding or bruising
- Severe fatigue or weakness
- Numbness, tingling, or pain in hands or feet
- Significant swelling in hands, feet, or ankles
- Shortness of breath or difficulty breathing
- Severe skin rash, redness, or peeling
- Severe nausea, vomiting, or diarrhea
- Severe mouth sores
- Signs of an allergic reaction during or after infusion (e.g., hives, itching, flushing, dizziness, chest tightness, difficulty breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking any of the following medications: atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, or voriconazole.
* If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication and for 1 week after your last dose.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. Additionally, inform them about any health problems you have. Your doctor will help you determine whether it is safe to take this medication with your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
To ensure your safety, avoid driving and other activities that require alertness and clear vision until you understand how this medication affects you. Note that this medication contains alcohol, which may cause feelings of intoxication during and after treatment. If you experience confusion, dizziness, stumbling, or excessive sleepiness during or within 1 to 2 hours after treatment, inform your doctor. Additionally, consult your doctor before consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter medications that may impair your reactions.
As this medication may increase your risk of infection, practice good hygiene by washing your hands frequently and avoiding close contact with individuals who have infections, colds, or flu. You may also be more prone to bleeding, so exercise caution to avoid injury, use a soft toothbrush, and consider using an electric razor.
Before receiving any vaccinations, discuss the potential risks and benefits with your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication. Although rare, there is a possibility of developing other types of cancer, including certain blood cancers and kidney cancer, when using this medication in combination with other cancer treatments. This risk may occur months to years after treatment, so it is crucial to discuss any concerns with your doctor.
Some formulations of this medication may contain albumin, a component of blood, which can potentially transmit viruses. However, the medication is thoroughly screened, tested, and treated to minimize the risk of infection. If you have concerns, consult your doctor.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. This medication may also affect fertility, so discuss any concerns with your doctor. Furthermore, this medication can harm an unborn baby, and a pregnancy test will be conducted before initiating treatment to confirm that you are not pregnant.
If you or your partner may become pregnant, it is essential to use birth control during treatment and for a specified period after the last dose. Your doctor will advise you on the recommended duration of birth control. If you or your partner becomes pregnant, notify your doctor immediately.
Overdose Information
Overdose Symptoms:
- Bone marrow suppression (severe neutropenia, thrombocytopenia)
- Peripheral neurotoxicity
- Mucositis
What to Do:
There is no known antidote for docetaxel overdose. Management involves supportive care, including administration of G-CSF for neutropenia, platelet transfusions for thrombocytopenia, and symptomatic treatment for other toxicities. Call 1-800-222-1222 (Poison Control Center) or seek immediate medical attention.
Drug Interactions
Major Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, indinavir, nelfinavir, saquinavir, telithromycin, voriconazole, grapefruit juice) - may significantly increase docetaxel exposure and toxicity.
- Live vaccines - increased risk of infection.
Moderate Interactions
- Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin, phenobarbital, St. John's Wort) - may decrease docetaxel exposure and efficacy.
- Other myelosuppressive agents - increased risk of severe myelosuppression.
- Drugs metabolized by CYP3A4 (e.g., cyclosporine, paclitaxel, vinca alkaloids) - potential for altered metabolism of co-administered drugs.
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To assess baseline hematopoietic function, especially neutrophil count, as myelosuppression is a dose-limiting toxicity.
Timing: Prior to first dose
Rationale: To assess hepatic function, as docetaxel is extensively metabolized by the liver and hepatic impairment increases toxicity risk.
Timing: Prior to first dose
Rationale: To assess baseline renal function, although docetaxel is minimally renally excreted, overall patient health is important.
Timing: Prior to first dose
Rationale: To assess baseline fluid balance and monitor for fluid retention.
Timing: Prior to first dose
Rationale: To assess baseline peripheral neuropathy.
Timing: Prior to first dose
Routine Monitoring
Frequency: Prior to each cycle and weekly during the first cycle (or as clinically indicated)
Target: Absolute Neutrophil Count (ANC) ≥ 1500 cells/mm³; Platelets ≥ 100,000 cells/mm³
Action Threshold: ANC < 1500 cells/mm³ or platelets < 100,000 cells/mm³: Delay dose or reduce dose.
Frequency: Prior to each cycle
Target: Bilirubin ≤ ULN; AST/ALT ≤ 1.5 x ULN (or as per specific guidelines for hepatic impairment)
Action Threshold: Elevated LFTs beyond acceptable limits: Dose reduction or discontinuation.
Frequency: Prior to each cycle and regularly during treatment
Target: Stable weight, absence of significant edema
Action Threshold: Significant fluid retention: Consider diuretic therapy, adjust corticosteroid premedication, or dose modification.
Frequency: Prior to each cycle and as clinically indicated
Target: Absence of new or worsening neuropathy
Action Threshold: Grade 2 or higher peripheral neuropathy: Dose reduction or discontinuation.
Frequency: During and immediately after infusion
Target: Absence of signs/symptoms of hypersensitivity
Action Threshold: Signs of hypersensitivity (e.g., rash, dyspnea, hypotension): Stop infusion, administer appropriate treatment.
Symptom Monitoring
- Fever or chills (signs of infection/neutropenic fever)
- Unusual bleeding or bruising
- Fatigue or weakness
- Numbness, tingling, or burning sensation in hands or feet (peripheral neuropathy)
- Swelling in hands, feet, or ankles (fluid retention)
- Shortness of breath, cough
- Skin rash, redness, peeling, or blistering
- Nausea, vomiting, diarrhea, constipation
- Mouth sores (mucositis)
- Hair loss (alopecia)
- Changes in vision or eye pain
- Signs of allergic reaction during infusion (e.g., flushing, hives, difficulty breathing, chest tightness)
Special Patient Groups
Pregnancy
Docetaxel can cause fetal harm when administered to a pregnant woman. It is classified as Pregnancy Category D. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment and for 6 months after the last dose. Advise males with female partners of reproductive potential to use effective contraception during treatment and for 3 months after the last dose.
Trimester-Specific Risks:
Lactation
It is not known whether docetaxel is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in breastfed infants, women should not breastfeed during docetaxel treatment and for 1 week after the last dose.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Docetaxel is not indicated for use in pediatric patients.
Geriatric Use
No overall differences in effectiveness were observed between elderly (≥65 years) and younger patients. However, elderly patients may be more prone to certain adverse reactions, such as fluid retention, neutropenia, and fatigue. Close monitoring is recommended.
Clinical Information
Clinical Pearls
- Premedication with oral corticosteroids (e.g., dexamethasone 8 mg twice daily for 3 days, starting 1 day prior to docetaxel infusion) is crucial to reduce the incidence and severity of fluid retention and hypersensitivity reactions.
- Monitor CBC frequently, especially during the first cycle, as neutropenia is the most common and dose-limiting toxicity. G-CSF may be used for prophylaxis or treatment of neutropenia.
- Fluid retention can be cumulative and may manifest as peripheral edema, pleural effusion, or ascites. Monitor weight and fluid status closely.
- Peripheral neuropathy is a common side effect; monitor for symptoms and consider dose reduction or discontinuation if severe.
- Docetaxel is a vesicant/irritant; administer via a central venous catheter if possible, or ensure proper peripheral IV access and monitor for extravasation.
- Patients should be advised to avoid grapefruit and grapefruit juice due to potential CYP3A4 interaction.
- Nail changes (onycholysis, discoloration) and skin reactions (rash, desquamation) are common and can be distressing; provide supportive care and patient education.
Alternative Therapies
- Paclitaxel (another taxane)
- Other cytotoxic agents depending on cancer type (e.g., anthracyclines, platinum compounds, antimetabolites)
- Targeted therapies (e.g., trastuzumab, pertuzumab for HER2+ breast cancer)
- Immunotherapy (e.g., pembrolizumab, nivolumab)
- Hormonal therapies (e.g., tamoxifen, aromatase inhibitors for breast cancer; abiraterone, enzalutamide for prostate cancer)